Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
Status:
Completed
Trial end date:
2012-06-30
Target enrollment:
Participant gender:
Summary
It is hypothesized that zirconium silicate is safe and well tolerated and more effective than
placebo (alternative hypothesis) in lowering serum potassium levels in subjects with serum
potassium between 5 - 6.0 mmol/l versus no difference between zirconium silicate and placebo
(null hypothesis). It is hypothesized that zirconium silicate even up to the top dose of 10g
three times a day is well tolerated.